Osaka bans public smoking ahead of Expo 2025
One of Japan's biggest cities is 'beautifying' itself ahead of hosting the World Expo — not by planting flowers, but by banning cigarettes.
Osaka will soon host Expo 2025, which runs from April to October, with representatives from 158 countries and regions participating in talks, demonstrations and exhibitions.
The ban on public smoking, which took effect on January 27, includes roads, parks, plazas and other public places and applies not only to cigarettes, but also to vapes. Violators will be fined 1,000 yen (about $6).
'Osaka City will expand its no-smoking areas to cover the entire city to enhance safety, cleanliness and its image as an international tourist destination,' city officials announced in a statement earlier this month. 'This initiative aims not only to beautify the city but also to ensure a safe, secure and comfortable living environment for residents and visitors.'
Current national laws largely ban smoking in establishments such as restaurants, offices and public transportation, and some cities have bans in public places. It is also illegal for people under the age of 20 to smoke and buy tobacco.
However, throughout Japan, it's common for airports, train stations and other public buildings to have dedicated smoking rooms.
The World Health Organization estimates that the number of Japanese people who use tobacco and smoke cigarettes has roughly halved over the past two decades, declining from around 32% in 2000 to around 16% in 2022.
A 2022 survey by Japan's Ministry of Health (MOH) found that 14.8% of adults smoke. The MOH has set a goal of lowering the national smoking rate to 12%.
Compare that to the United States, where in 2022, 19.8% — nearly 1 in 5 — US adults reported current tobacco product use, according to the Centers for Disease Control and Prevention.
After announcing the strict new rules around public tobacco use, Osaka's local government created a map showing where in the city it is still okay to light up.
Similar anti-smoking measures have been implemented in other parts of Japan, including in Tokyo ahead of the 2020 Olympics, which have remained in place ever since.
Some public figures have even been called out in the past for smoking underage.
Arguably the most famous recent example was Shoko Miyata, captain of Japan's women's gymnastics team. Miyata withdrew from the Summer Olympics in Paris last year after admitting to smoking and drinking. She was 19 at the time.
The six-month Expo 2025 runs from April 13 until October 13. The city has spent 164.7 billion yen ($1.16 billion) on the event, including major urban infrastructure projects.
CNN Travel named the Kansai region — which includes Osaka — as one of its 25 places to visit in 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant NB.1.8.1 spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UKHSA recorded the first 13 cases in England last week. However, the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent one month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at Pall Mall Medical, added: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Dr Asif. Common symptoms of the NB.1.8.1 variant include a severe sore throat. fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
Politico
8 hours ago
- Politico
What to know about Trump's travel ban taking effect Monday
DAKAR, Senegal — President Donald Trump has banned citizens of 12 countries from entering the United States and restricted access for those from seven others, citing national security concerns in resurrecting and expanding a hallmark policy from his first term that will mostly affect people from Africa and the Middle East. The ban announced Wednesday applies to citizens of Afghanistan, Myanmar, Chad, the Republic of Congo, Equatorial Guinea, Eritrea, Haiti, Iran, Libya, Somalia, Sudan and Yemen. The heightened restrictions apply to people from Burundi, Cuba, Laos, Sierra Leone, Togo, Turkmenistan and Venezuela who are outside the U.S. and don't hold a valid visa. The policy takes effect Monday at 12:01 a.m. and does not have an end date. Here's what to know about the new rules: Since returning to the White House, Trump has launched an unprecedented campaign of immigration enforcement that has pushed the limits of executive power and clashed with federal judges trying to restrain him. The travel ban stems from a Jan. 20 executive order Trump issued requiring the Department of State, Department of Homeland Security and the Director of National Intelligence to compile a report on 'hostile attitudes' toward the U.S. The aim is to 'protect its citizens from aliens who intend to commit terrorist attacks, threaten our national security, espouse hateful ideology, or otherwise exploit the immigration laws for malevolent purposes,' the administration said. In a video posted on social media, Trump tied the new ban to a terrorist attack last Sunday in Boulder, Colorado, saying it underscored the dangers posed by some visitors who overstay visas. The man charged in the attack is from Egypt, a country that is not on Trump's restricted list. U.S. officials say he overstayed a tourist visa. 1. Green card holders2. Dual citizens, including U.S. citizens who also have citizenship of one of the banned countries3. Some athletes: athletes and their coaches traveling to the U.S. for the World Cup, Olympics or other major sporting event as determined by the U.S. secretary of state4. Afghans who worked for the U.S. government or its allies in Afghanistan and are holders of Afghan special immigrant visas5. Iranians belonging to an ethnic or religious minority who are fleeing prosecution6. Certain foreign national employees of the U.S. government who have served abroad for at least 15 years, and their spouses and children7. People who were granted asylum or admitted to the U.S. as refugees before the ban took effect8. People with U.S. family members who apply for visas in connection to their spouses, children or parents9. Diplomats and foreign government officials on official visits10. Those traveling to U.N. headquarters in New York solely on official U.N. business11. Representatives of international organizations and NATO on official visits in the U.S.12. Children adopted by U.S. citizens13. People from targeted countries who already have valid visas, although the Department of Homeland Security still has the authority to deny entry, even to those with a valid visa Trump said nationals of countries included in the ban pose 'terrorism-related' and 'public-safety' risks, as well as risks of overstaying their visas. He also said some of these countries had 'deficient' screening and vetting or have historically refused to take back their citizens. His findings rely extensively on an annual Homeland Security report about tourists, businesspeople and students who overstay U.S. visas and arrive by air or sea, singling out countries with high percentages of nationals who remain after their visas expired. 'We don't want them,' Trump said. The inclusion of Afghanistan angered some supporters who have worked to resettle its people. The ban makes exceptions for Afghans on special immigrant visas, who were generally the people who worked most closely with the U.S. government during the two-decade war there. The list can be changed, the administration said in a document, if authorities in the designated countries make 'material improvements' to their own rules and procedures. New countries can be added 'as threats emerge around the world.' The State Department instructed U.S. embassies and consulates on Friday not to revoke visas previously issued to people from the 12 countries listed in the ban. In a cable sent to all U.S. diplomatic missions, the department said 'no action should be taken for issued visas which have already left the consular section' and that 'no visas issued prior to the effective date should be revoked pursuant to this proclamation.' However, visa applicants from affected countries whose applications have been approved but have not yet received their visas will be denied, according to the cable, which was signed by Secretary of State Marco Rubio. And, unless an applicant meets narrow criteria for an exemption to the ban, his or her application will be rejected starting on Monday. Early in Trump's first term, he issued an executive order banning travel to the U.S. by citizens of seven predominantly Muslim countries: Iraq, Syria, Iran, Sudan, Libya, Somalia and Yemen. It was one of the most chaotic and confusing moments of his young presidency. Travelers from those nations were either barred from getting on flights to the U.S. or detained at U.S. airports after they landed. They included students and faculty, as well as businesspeople, tourists and people visiting friends and family. The order, often referred to as the 'Muslim ban' or the 'travel ban,' was retooled amid legal challenges until a version was upheld by the Supreme Court in 2018. That ban affected various categories of travelers and immigrants from Iran, Somalia, Yemen, Syria and Libya, plus North Koreans and some Venezuelan government officials and their families.
Business Wire
10 hours ago
- Business Wire
Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. ('Samsung Bioepis') announced today that the company has entered into a license, development and commercialization agreement with NIPRO Corporation ('NIPRO') for multiple biosimilar candidates including SB17, ustekinumab biosimilar candidate, in Japan. 'This partnership marks an important step towards expanding our footprint in Japan. Biosimilars have a great potential to bring cost savings and widen access to treatments for healthcare systems, providers, and patients in Japan." Share Under the terms of the agreement, Samsung Bioepis will be responsible for the development, manufacture and supply of the medicines, while NIPRO will be responsible for commercialization of the medicines in Japan. 'This partnership marks an important step towards expanding our footprint in Japan. Biosimilars have a great potential to bring cost savings and widen access to treatments for healthcare systems, providers, and patients in Japan. We look forward to collaborating with NIPRO, a company renowned for its high-quality medical devices and healthcare solutions, to accelerate access to treatments in the Japanese market,' said Kyung-Ah Kim, President and Chief Executive Officer of Samsung Bioepis. 'We will continue to advance our development platform and innovate access to treatments for healthcare systems, payers, physicians, and patients around the world.' About Samsung Bioepis Co., Ltd. Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology, ophthalmology, hematology, nephrology, and endocrinology. For more information, please visit: and follow us on social media – LinkedIn, X.
